What is he best known for?
The fields of study he is best known for:
His main research concerns Multiple drug resistance, ATP-binding cassette transporter, Pharmacology, Efflux and Biochemistry.
His Multiple drug resistance research is multidisciplinary, incorporating elements of Molecular biology, Multidrug Resistance-Associated Proteins and Cell culture.
The various areas that he examines in his ATP-binding cassette transporter study include P-glycoprotein and Intracellular.
His studies in Pharmacology integrate themes in fields like Paclitaxel, Chemotherapy, Cancer cell, Tyrosine kinase and Tyrosine-kinase inhibitor.
His work deals with themes such as Cancer research, Abcg2 and Nilotinib, which intersect with Tyrosine-kinase inhibitor.
His Efflux study integrates concerns from other disciplines, such as ABCC6, Membrane protein, Membrane transport and Multidrug resistance-associated protein 2.
His most cited work include:
- Silver nanoparticles: synthesis, properties, and therapeutic applications. (411 citations)
- Biosynthesis of nanoparticles by microorganisms and their applications (411 citations)
- The development of anticancer ruthenium(II) complexes: from single molecule compounds to nanomaterials (397 citations)
What are the main themes of his work throughout his whole career to date?
Zhe-Sheng Chen focuses on Multiple drug resistance, Pharmacology, Efflux, ATP-binding cassette transporter and Cancer research.
His work carried out in the field of Multiple drug resistance brings together such families of science as Cancer cell, Abcg2 and Intracellular.
His Pharmacology research is multidisciplinary, relying on both Paclitaxel, ABCC1, Doxorubicin, Tyrosine-kinase inhibitor and In vivo.
He works mostly in the field of Efflux, limiting it down to concerns involving Molecular biology and, occasionally, Cell culture, Transfection and Epidermoid carcinoma.
His ATP-binding cassette transporter research incorporates themes from Tyrosine kinase and Subfamily.
Zhe-Sheng Chen interconnects Cancer, Cell cycle and Apoptosis in the investigation of issues within Cancer research.
He most often published in these fields:
- Multiple drug resistance (53.09%)
- Pharmacology (44.38%)
- Efflux (33.71%)
What were the highlights of his more recent work (between 2019-2021)?
- Multiple drug resistance (53.09%)
- Cancer research (28.37%)
- Abcg2 (25.84%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Multiple drug resistance, Cancer research, Abcg2, Cancer cell and Efflux.
His biological study spans a wide range of topics, including Transporter, ATP-binding cassette transporter, Intracellular, Cytotoxicity and Pharmacology.
His studies deal with areas such as Computational biology and Transfection as well as ATP-binding cassette transporter.
His Cancer research study combines topics from a wide range of disciplines, such as Cancer, Colorectal cancer, Cell cycle and Drug resistance.
The study incorporates disciplines such as Molecular biology, Cell and Clinical trial in addition to Cancer cell.
His Efflux study combines topics in areas such as IC50, P-glycoprotein, ABCC10 and Protein kinase A.
Between 2019 and 2021, his most popular works were:
- Medicinal chemistry strategies to discover P-glycoprotein inhibitors: An update. (37 citations)
- Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistance. (33 citations)
- Long non-coding RNAs regulate drug resistance in cancer (29 citations)
In his most recent research, the most cited papers focused on:
His primary areas of study are Multiple drug resistance, Cancer research, Cancer cell, Drug resistance and Cancer.
His Multiple drug resistance research incorporates elements of Transporter, Abcg2, ATP-binding cassette transporter, Efflux and MTT assay.
His Efflux research includes elements of Clinical trial and Chemotherapy.
Zhe-Sheng Chen usually deals with Cancer cell and limits it to topics linked to PI3K/AKT/mTOR pathway and Downregulation and upregulation, Epidermoid carcinoma and Protein kinase B.
His Cancer research includes themes of Anticancer drug, Disulfiram, Drug, Pharmacology and Safety profile.
His study looks at the relationship between Pharmacology and fields such as Malaria, as well as how they intersect with chemical problems.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
